113 related articles for article (PubMed ID: 12573798)
1. VIP and PACAP display different vasodilatory effects in rabbit coronary and cerebral arteries.
Dalsgaard T; Hannibal J; Fahrenkrug J; Larsen CR; Ottesen B
Regul Pept; 2003 Feb; 110(3):179-88. PubMed ID: 12573798
[TBL] [Abstract][Full Text] [Related]
2. Long-term estradiol treatment improves VIP-mediated vasodilation in atherosclerotic proximal coronary arteries.
Dalsgaard T; Mortensen A; Larsen CR; Larsen JJ; Ottesen B
Regul Pept; 2003 Nov; 116(1-3):155-62. PubMed ID: 14599727
[TBL] [Abstract][Full Text] [Related]
3. The effects of pituitary adenylate cyclase-activating polypeptide on cerebral arteries and vertebral artery blood flow in anesthetized dogs.
Seki Y; Suzuki Y; Baskaya MK; Kano T; Saito K; Takayasu M; Shibuya M; Sugita K
Eur J Pharmacol; 1995 Mar; 275(3):259-66. PubMed ID: 7768293
[TBL] [Abstract][Full Text] [Related]
4. Pituitary adenylate cyclase-activating polypeptide, helospectin, and vasoactive intestinal polypeptide in human corpus cavernosum.
Hedlund P; Alm P; Ekström P; Fahrenkrug J; Hannibal J; Hedlund H; Larsson B; Andersson KE
Br J Pharmacol; 1995 Oct; 116(4):2258-66. PubMed ID: 8564257
[TBL] [Abstract][Full Text] [Related]
5. Receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in the goose cerebral cortex.
Zawilska JB; Niewiadomski P; Nowak JZ
Pol J Pharmacol; 2004; 56(2):203-11. PubMed ID: 15156071
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical localization of the VIP1 receptor (VPAC1R) in rat cerebral blood vessels: relation to PACAP and VIP containing nerves.
Fahrenkrug J; Hannibal J; Tams J; Georg B
J Cereb Blood Flow Metab; 2000 Aug; 20(8):1205-14. PubMed ID: 10950381
[TBL] [Abstract][Full Text] [Related]
7. Vascular effects and cyclic AMP production produced by VIP, PHM, PHV, PACAP-27, PACAP-38, and NPY on rabbit ovarian artery.
Yao W; Sheikh SP; Ottesen B; Jørgensen JC
Peptides; 1996; 17(5):809-15. PubMed ID: 8844771
[TBL] [Abstract][Full Text] [Related]
8. Vascular effects of pituitary adenylate cyclase activating peptide: a comparison with vasoactive intestinal peptide.
Absood A; Chen D; Wang ZY; Håkanson R
Regul Pept; 1992 Aug; 40(3):323-9. PubMed ID: 1332142
[TBL] [Abstract][Full Text] [Related]
9. VPAC2-R mediates the lipolytic effects of pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide in primary rat adipocytes.
Akesson L; Ahrén B; Edgren G; Degerman E
Endocrinology; 2005 Feb; 146(2):744-50. PubMed ID: 15514088
[TBL] [Abstract][Full Text] [Related]
10. Backup Mechanisms Maintain PACAP/VIP-Induced Arterial Relaxations in Pituitary Adenylate Cyclase-Activating Polypeptide-Deficient Mice.
Ivic I; Fulop BD; Juhasz T; Reglodi D; Toth G; Hashimoto H; Tamas A; Koller A
J Vasc Res; 2017; 54(3):180-192. PubMed ID: 28490016
[TBL] [Abstract][Full Text] [Related]
11. Aging-Induced Modulation of Pituitary Adenylate Cyclase-Activating Peptide- and Vasoactive Intestinal Peptide-Induced Vasomotor Responses in the Arteries of Mice.
Ivic I; Solymar M; Fulop BD; Hashimoto H; Toth G; Tamas A; Juhasz T; Koller A; Reglodi D
J Vasc Res; 2017; 54(6):359-366. PubMed ID: 29131060
[TBL] [Abstract][Full Text] [Related]
12. VIP/PACAP receptors in cerebral arteries of rat: characterization, localization and relation to intracellular calcium.
Erdling A; Sheykhzade M; Maddahi A; Bari F; Edvinsson L
Neuropeptides; 2013 Apr; 47(2):85-92. PubMed ID: 23375386
[TBL] [Abstract][Full Text] [Related]
13. The vasorelaxant effect of pituitary adenylate cyclase activating polypeptide and vasoactive intestinal polypeptide in isolated rat basilar arteries is partially mediated by activation of nitrergic neurons.
Seebeck J; Löwe M; Kruse ML; Schmidt WE; Mehdorn HM; Ziegler A; Hempelmann RG
Regul Pept; 2002 Jul; 107(1-3):115-23. PubMed ID: 12137973
[TBL] [Abstract][Full Text] [Related]
14. PACAP, a VIP-like peptide: immunohistochemical localization and effect upon cat pial arteries and cerebral blood flow.
Uddman R; Goadsby PJ; Jansen I; Edvinsson L
J Cereb Blood Flow Metab; 1993 Mar; 13(2):291-7. PubMed ID: 8436621
[TBL] [Abstract][Full Text] [Related]
15. Characterization of vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptors in human benign hyperplastic prostate.
Solano RM; Carmena MJ; Carrero I; Cavallaro S; Roman F; Hueso C; Travali S; Lopez-Fraile N; Guijarro LG; Prieto JC
Endocrinology; 1996 Jul; 137(7):2815-22. PubMed ID: 8770902
[TBL] [Abstract][Full Text] [Related]
16. PACAP and VIP differentially preserve neurovascular reactivity after global cerebral ischemia in newborn pigs.
Lenti L; Zimmermann A; Kis D; Oláh O; Tóth GK; Hegyi O; Busija DW; Bari F; Domoki F
Brain Res; 2009 Aug; 1283():50-7. PubMed ID: 19538945
[TBL] [Abstract][Full Text] [Related]
17. Pituitary adenylate cyclase-activating polypeptide does not colocalize with vasoactive intestinal polypeptide in the hypothalamic magnocellular nuclei and posterior pituitary of cats and rats.
Vereczki V; Köves K; Tóth ZE; Baba A; Hashimoto H; Fógel K; Arimura A; Kausz M
Endocrine; 2003 Dec; 22(3):225-37. PubMed ID: 14709795
[TBL] [Abstract][Full Text] [Related]
18. Differential expression of pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide receptor subtypes in clonal pituitary somatotrophs and gonadotrophs.
Rawlings SR; Piuz I; Schlegel W; Bockaert J; Journot L
Endocrinology; 1995 May; 136(5):2088-98. PubMed ID: 7720658
[TBL] [Abstract][Full Text] [Related]
19. Receptors for VIP and PACAP in guinea pig cerebral cortex: effects on cyclic AMP synthesis and characterization by 125I-VIP binding.
Zawilska JB; Dejda A; Niewiadomski P; Gozes I; Nowak JZ
J Mol Neurosci; 2005; 25(3):215-24. PubMed ID: 15800375
[TBL] [Abstract][Full Text] [Related]
20. Vasoactive intestinal peptide (VIP) like peptides in the cerebral circulation of the cat.
Jansen-Olesen I; Goadsby PJ; Uddman R; Edvinsson L
J Auton Nerv Syst; 1994 Sep; 49 Suppl():S97-103. PubMed ID: 7836694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
